We are live on ! Find out more
WVE icon

Wave Life Sciences
WVE

91 hedge funds and large institutions have $306M invested in Wave Life Sciences in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 9

42% more call options, than puts

Call options by funds: $1.71M | Put options by funds: $1.21M

17% more funds holding

Funds holding: 78 → 91 (+13)

17% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 24

9% more capital invested

Capital invested by funds: $282M → $306M (+$24.2M)

4.8% less ownership

Funds ownership: 87.15% → 82.35% (-4.8%)

Holders
91
Holders Change
+13
Holders Change %
+16.67%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
28
Reduced
24
Closed
9
Calls
$1.71M
Puts
$1.21M
Net Calls
+$504K
Net Calls Change
-$1.42M

Top Buyers

1
NCM
Nantahala Capital Management
Connecticut
+$7.28M
2
GTC
Ghost Tree Capital
New York
+$5.03M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.99M
4
BlackRock
BlackRock
New York
+$4.6M
5
Morgan Stanley
Morgan Stanley
New York
+$4.36M

Top Sellers

1
RG
Redmile Group
California
-$23.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$18.6M
3
RI
RTW Investments
New York
-$9.4M
4
SIM
Spark Investment Management
New York
-$754K
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$622K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$80.9M – – –
BG
2
Bellevue Group
Switzerland
$27.1M – – –
RI
3
RTW Investments
New York
$24.9M -$9.4M -999,437 -29%
BlackRock
4
BlackRock
New York
$24M +$4.6M +488,805 +27%
NCM
5
Nantahala Capital Management
Connecticut
$18.2M +$7.28M +773,207 +79%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$13.7M +$2.18M +231,446 +21%
Primecap Management
7
Primecap Management
California
$13.7M +$758K +80,566 +7%
Morgan Stanley
8
Morgan Stanley
New York
$12M +$4.36M +462,965 +68%
Wellington Management Group
9
Wellington Management Group
Massachusetts
$11M -$18.6M -1,971,431 -65%
JP Morgan Chase
10
JP Morgan Chase
New York
$8.32M +$173K +18,367 +2%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$5.85M +$4.99M +529,849 +1,650%
GTC
12
Ghost Tree Capital
New York
$5.57M +$5.03M +535,000 New
State Street
13
State Street
Massachusetts
$4.88M -$378K -40,155 -8%
Vanguard Group
14
Vanguard Group
Pennsylvania
$4.45M +$140K +14,919 +4%
RG
15
Redmile Group
California
$4.32M -$23.6M -2,512,197 -86%
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$3.93M +$3.44M +365,416 +3,051%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$3.12M +$53.5K +5,691 +2%
SFM
18
Sphera Funds Management
Israel
$3.05M +$2.76M +293,000 New
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$2.98M +$2.69M +286,116 New
Northern Trust
20
Northern Trust
Illinois
$2.97M +$1.45K +154 +0.1%
PAMU
21
Pictet Asset Management (UK)
United Kingdom
$1.82M -$186K -19,746 -10%
MAM
22
Martingale Asset Management
Massachusetts
$1.46M +$1.32M +140,313 New
Arrowstreet Capital
23
Arrowstreet Capital
Massachusetts
$1.46M +$1.32M +139,877 New
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$1.42M +$615K +65,312 +91%
TCM
25
Tekla Capital Management
Massachusetts
$1.33M – – –
1
2 3 4

WVE Hedge Fund Activity: Q2 2020 in Review

91 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2020, worth a combined $306M — up 8.6% from $282M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new WVE positions and 9 closed out — a net gain of 13 holders — while 28 added to existing stakes and 24 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $7.28M. The largest seller was Redmile Group, cutting an estimated $23.6M.

  • 91 institutional investors held Wave Life Sciences (WVE) as of Q2 2020, up from 78 in Q1 2020.
  • Funds reported $306M of Wave Life Sciences stock for Q2 2020, up 8.6% quarter-over-quarter.
  • 22 funds opened new Wave Life Sciences positions in Q2 2020 and 9 closed out, a net change of +13 holders.
  • The largest Wave Life Sciences buyer in Q2 2020 was Nantahala Capital Management, an estimated $7.28M added.
  • The largest Wave Life Sciences seller in Q2 2020 was Redmile Group, an estimated $23.6M sold.

Based on aggregated 13F filings for Q2 2020.